Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...
Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...
Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...
Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...
Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...
After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...
Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...
Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...
Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...
Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...
Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...
Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...
